What’s New in Treatment for Acute Myeloid Leukemia (AML)

Olatoyosi Odenike, MD and Wendy Stock, MD

Recorded on January 15, 2021

Join Drs. Wendy Stock and Olatoyosi Odenike from The University of Chicago Medicine, in an important discussion on the progress in the treatment of acute myeloid leukemia, including important updates from the LLS Beat AML Master Trial. Drs. Stock and Odenike talk with Dr. Ken Miller about determining a treatment plan for each patient, the role genetics and epigenetics may play, what the ultimate goals of care are, including having difficult conversations with patients regarding treatment, and monitoring for measurable residual disease and maintenance therapy. Be a part of the conversation today!

JML Olatoyosi Odenike, MD
Professor of Medicine
Director, Leukemia Program
Section of Hematology/Oncology
The University of Chicago Medicine
Chicago, IL
sulis Wendy Stock, MD
Anjuli Seth Nayak Professor of Leukemia Research
The University of Chicago Medicine
Chicago, IL

Leave a Reply

Your email address will not be published. Required fields are marked *